Skip to main content

Table 1 Patient Demographics, Diagnosis, and Medical History

From: Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine

Variable

n (%)

Mean (SD)

Age (years; N = 4508)

 

52.2 (12.7)

Gender: Female (N = 4513)

3241 (71.8)

 

BMI (kg/m2; N = 4503)

 

27.1 (5.1)

Living alone (N = 4261)

1113 (26.1)

 

Currently unable to work a (N = 4321)

1708 (39.5)

 

Duration of inability to work in the last 12 months (weeks; N = 4140)

 

6.3 (13.1)

Diagnosis by ICD Code (reported by > 5% of patients; N = 4493)

  

   Moderate depressive episode (F32.1)

1376 (30.6)

 

   Recurrent depressive disorder, current episode moderate (F33.1)

1204 (26.8)

 

   Severe depressive episode without psychotic symptoms (F32.2)

569 (12.7)

 

   Recurrent depressive disorder, current episode severe without psychotic symptoms (F33.2)

362 (8.1)

 

   Depressive episode, unspecified (F32.9)

347 (7.7)

 

Age at onset of depression (years; N = 4445)

 

41.5 (14.3)

Time since onset of depression (years; N = 4442)

 

10.6 (10.7)

Any hospitalization during the last 12 months (N = 4485)

473 (10.5)

 

Any suicide attempt during the last 12 months (N = 4473)

102 (2.3)

 

Any concomitant psychiatric diseases (N = 4501)

2032 (45.2)

 

   Most common (> 10% of patients) concomitant psychiatric diseases: b

  

   Somatoform disorders

1269 (28.2)

 

   Anxiety disorders/obsessive-compulsive disorders

661 (14.7)

 

   Further psychiatric diseases

497 (11.0)

 

History of antidepressant therapy in the last week (N = 4500) yes

2678 (59.5)

 

   Most common (> 5% of patients) antidepressant therapies:

  

   Tricyclic antidepressant

1320 (29.3)

 

   Selective serotonin reuptake inhibitor

1063 (23.6)

 

   Noradrenergic and specific serotonergic antidepressant

385 (8.6)

 

   Selective serotonin and noradrenaline reuptake inhibitor

234 (5.2)

 

Patients with overall pain VAS > 30 mm

3525 (80.0)

 

Any permanent pain medication (N = 4503)

1453 (32.3)

 

Any on-demand pain medication in the last 12 months (N = 4481)

2728 (60.9)

 

Any concomitant somatic diseases (N = 4495)

3241 (72.1)

 

   Most common (> 10% of patients) concomitant somatic diseases: b

  

   Muscle and skeleton diseases

1514 (33.7)

 

   Hypertension

1258 (28.0)

 

   Neurologic diseases

555 (12.3)

 

   Metabolic diseases

503 (11.2)

 

   Gastrointestinal diseases

470 (10.5)

 

   Allergies

467 (10.4)

 
  1. BMI = Body mass index; N = Number of patients with available data; n = Number of patients in category; SD = Standard deviation.
  2. a Answer 'yes' to the question 'Is the patient unable to work today?'.
  3. b As selected from the check list.